Premedication, Preparation, and Surveillance

Once again the staggering variation in IV sedation practice between different countries is highlighted. This year the „to sedate or not sedate” debate focuses on colonoscopy. Several papers on the use of Propofol are reviewed. It remains this authors' opinion that propofol is an anaesthetic agent to be used by (or at least in the presence of) an anaesthetist. Informed consent and the question of what to do if a patient withdraws consent halfway through the procedure are discussed. Predictably further recent papers on the relative merits of midazolam and diazepam are presented plus another report on the use of flumazenil in the recovery period. The use of 3 % hydrogen peroxide solution to aid the visualization of acutely bleeding gastro-duodenal lesions is presented in two papers along with a discussion of its possible mode of action. The use of antispasmodics to aid colonoscopy is further discussed: this year concentrating on the use of hyoscyamine sulphate (as opposed to hyoscine butylbromide, the preferred agent in the UK). The patients receiving hyoscyamine sulphate had significantly shorter caecal intubation times, better sedation and easier colonic insertion. The „downside” was drug-induced tachycardia and the authors caution against the widespread use of this drug until this situation is further clarified. The subject of hypoxaemia at the time of gastroscopy, colonoscopy and ERCP was reviewed last year and further papers are presented in which the incidence of various levels of hypoxia are given. In anaesthetic circles it would be considered totally unacceptable to allow a patient's oxygen saturation to fall below 85 %, and yet we continue to have papers reporting its incidence. This level of desaturation is potential dangerous and the routine use of supplemental oxygen would greatly reduce this unneccessary risk to patients.

References (Key References are highlighted)

• 1 Lazzaroni M, Bianco-Porro G. Premedication, preparation and surveillance [review].  Endoscopy. 1999;  31 2-8
• 2 Whitwam JG, McCloy RF. Principles and practice of sedation. 2nd ed.  Oxford; Blackwell Science, 1998
• 3 Freeman ML. Sedation and monitoring for gastrointestinal endoscopy. In: Yamada T, Alpers DH, Laine L, et al (eds). Textbook of gastroenterology. 3rd ed.  Philadelphia; Lippincott, 1999: 2655-2667
• 4 Le Fanu J. The rise and fall of modern medicine.  London; Little Brown, 1999
• 5 Zaman A, Hahn M, Hapke K, et al. A randomized trial of peroral versus transnasal unsedated endoscopy using an ultrathin videoendoscope.  Gastrointest Endosc. 1999;  49 279-284
• 6 Dumortier J, Ponchon T, Scoazec JY, et al. Prospective evaluation of transnasal esophagogastroduodenoscopy: feasibility and study on performance and tolerance.  Gastrointest Endosc. 1999;  49 285-291
• 7 Graig A, Hanlon J, Dent J, Schoeman M. A comparison of transnasal and transoral endoscopy with small-diameter endoscopes in unsedated patients.  Gastrointest Endosc. 1999;  49 292-296
• 8 Saeian K, Townsend WF, Rochling FA, et al. Unsedated transnasal EGD: an alternative approach to conventional esophagoduodenoscopy for documenting Helicobacter pylori eradication.  Gastrointest Endosc. 1999;  49 297-301
• 9 Sivak MV . The nose: is this the route to improving esophagoduodenoscopy? [editorial].  Gastrointest Endosc. 1999;  49 395-398
• 10 Gopal DV, Zaman A, Katon RM. A role for transnasal esophagoduodenoscopy in patients intolerant to the oral route: report of two cases.  Gastrointest Endosc. 1999;  49 379-381
• 11 Williams CB. Colonoscopy and flexible sigmoidoscopy. In: Cotton PB, Williams CB (eds). Practical gastrointestinal endoscopy.  Oxford; Blackwell Science, 1996: 187-274
• 12 Waye JD, Williams CB. Colonoscopy and flexible sigmoidoscopy. In: Yamada T, Alpers DH, Laine L, et al (eds). Textbook of gastroenterology. 3rd ed.  Philadelphia; Lippincott, 1999: 2701-2717
• 13 Greff M. Colorectal cancer screening in France: guidelines and professional reality.  Endoscopy. 1999;  31 471
• 14 Eckardt VS , Kanzler G, Schmitt T, et al. Complications and adverse effects of colonoscopy with selective sedation.  Gastrointest Endosc. 1999;  49 560-565
• 15 Ristikankare M , Hartikainen J, Heikkinen M, et al. Is routinely given conscious sedation of benefit during colonoscopy?.  Gastrointest Endosc. 1999;  49 566-572
• 16 Rex DJ , Imperiale TF, Portish V. Patients willing to try colonoscopy without sedation: associated clinical factors and results of a randomized controlled trial.  Gastrointest Endosc. 1999;  49 554-559
• 17 Ward B, Shah S, Kirwan P Mayberry JF. Issues of consent in colonoscopy: if a patient says “stop” should we continue ?.  J R Soc Med. 1999;  92 132-133
• 18 Bell GD, Neale G, Wilkinson M, et al. Guidelines for informed consent for endoscopic procedures.  London [http://www.bsg.org.uk/guidelines/consent.html]; British Society of Gastroenterology, 1999: 132-133
• 19 Neale G . Reducing risks in gastroenterological practice.  Gut. 1998;  42 139-142
• 20 Bell GD. Premedication and i.v. sedation for upper gastrointestinal endoscopy.  Aliment Pharmacol Ther. 1990;  4 103-122
• 21 Bell GD, Spickett GP, Reeve P, et al. Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient.  Br J Clin Pharmacol. 1987;  23 241-243
• 22 Smith M, Bell GD, Quine A, et al. Small bolus injections of intravenous midazolam for upper gastrointestinal endoscopy: a study of 788 consecutive cases.  Br J Clin Pharmacol. 1993;  36 573-578
• 23 Quine MA, Bell GD, McCloy RF, et al. Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing and sedation methods.  Gut. 1995;  36 462-467
• 24 Zakko SF , Seifert HA, Gross JB. A comparison of midazolam and diazepam for conscious sedation during colonoscopy in a prospective double-blind study.  Gastrointest Endosc. 1999;  49 684-689
• 25 Assy N , Rosser BG, Grahame GR, Minuk GY. The risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis.  Gastrointest Endosc. 1999;  49 690-634
• 26 Chang AC, Solinger MA, Yang DT, Chen YK. Impact of flumazenil on recovery after outpatient endoscopy: a placebo-controlled trial.  Gastrointest Endosc. 1999;  49 573-579
• 27 Graber RG. Propofol in the endoscopy suite: an anesthesiologist's perspective [editorial].  Gastrointest Endosc. 1999;  49 803-806
• 28 Bell GD, Charlton JE. Colonoscopy: is sedation necessary and is there any role for i.v. propofol? [editorial].  Endoscopy . 2000;  32 [in press]
• 29 Short TG, Chiu PG. Propofol and midazolam act synergistically in combination.  Br J Anaesth. 1992;  67 539-545
• 30 Vinik HR. Propofol-alfentanil hypnotic interaction.  Anesth Analg. 1990;  71 65-69
• 31 Carlsson U, Grattidge P. Sedation for upper gastrointestinal endoscopy: a comparative study of propofol and midazolam.  Endoscopy. 1995;  27 240-245
• 32 Roseveare C, Seavell C, Patel P, et al. Patient-controlled sedation with propofol and alfentanil during colonoscopy: a pilot study.  Endoscopy. 1998;  30 482-483
• 33 Roseveare C , Seavell C, Patel P, et al. Patient-controlled sedation and analgesia, using propofol and alfentanil, during colonoscopy: a prospective randomized controlled trial.  Endoscopy. 1998;  30 768-773
• 34 Reimann FM , Samson U, Derad I, et al. Synergistic sedation with low-dose midazolam and propofol for colonoscopy.  Endoscopy. 2000;  32 [in press]
• 35 Ben-Shlomo I, Abd-El-Khalim H, Ezry J, et al. Midazolam acts synergistically with fentanyl for induction of anaesthesia.  Br J Anaesth. 1990;  64 45-47
• 36 Wehrmann T , Kokabpick S, Lembcke B, et al. Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study.  Gastrointest Endosc. 1999;  49 677-683
• 37 Saunders BP, Williams CB. Premedication with intravenous antispasmodic speeds up colonoscope insertion.  Gastrointest Endosc. 1996;  43 209-211
• 38 Marshall JB , Patel M, Mahajan RJ, et al. Benefit of intravenous antispasmodic (hyoscyamine sulfate) as premedication for colonoscopy.  Gastrointest Endosc. 1999;  49 720-726
• 39 Brandt LJ , Spinnell MK. Ability of naloxone to enhance the colonoscopic appearance of normal vasculature and colon vascular ectasias.  Gastrointest Endosc. 1999;  49 79-83
• 40 Brandt LJ, Mukhopadhyay D. Masking of colon vascular ectasias by cold water lavage [letter].  Gastrointest Endosc. 1999;  49 141-142
• 41 Baumann UA. Water intubation of the sigmoid colon: water instillation speeds up left-sided colonoscopy.  Endoscopy. 1999;  31 314-317
• 42 Rizzo J , Bernstein D, Gress F. A randomised double-blind placebo-controlled trial evaluating the cost-effectiveness of droperidol as a sedative premedication for EUS.  Gastrointest Endosc. 1999;  50 178-182
• 43 Charlton JE. Monitoring and supplemental oxygen during endoscopy [editorial].  Br Med J. 1995;  310 886-887
• 44 Bell GD, Bown NS, Morden A, et al. Prevention of hypoxaemia during upper gastrointestinal endoscopy using supplemental oxygen via nasal cannulae.  Lancet. 1987;  i 1022-1023
• 45 Bell GD, Jones JG. Routine use of pulse oximetry and supplemental oxygen during endoscopic procedures under conscious sedation: British beef or common sense? [editorial].  Endoscopy. 1996;  28 718-721
• 46 Allgayer H , Pohl C, Kruis W. Arterial oxygen desaturation during endoscopic ultrasonography combined with gastroscopy: a safety evaluation in outpatients.  Endoscopy. 1999;  31 447-451
• 47 Marscall HU, Bartels F. Life-threatening complications of nasogastric administration of polyethylene glycol-electrolyte solutions (GoLytely) for bowel cleansing.  Gastrointest Endosc. 1999;  49 408-410
• 48 Kallos AN , Canto MI, Wadwa KS, et al. Clinical usefulness of 3 % hydrogen peroxide in acute upper GI bleeding: a pilot study.  Gastrointest Endosc. 1999;  49 518-521
• 49 Wu DC , Lu CY, Lu YC, et al. Endoscopic hydrogen peroxide spray may facilitate localization of the bleeding site in acute upper gastrointestinal bleeding.  Endoscopy. 1999;  31 237-241
• 50 Schwab D, Raithel M, Ell C, Hahn EG. Severe shock during upper gastrointestinal endoscopy in a patient with severe systemic mastocytosis.  Gastrointest Endosc. 1999;  50 264-267